Evogene (EVGN) Tops Q3 EPS by 12c
Tweet
Share
E-mailEvogene (NASDAQ: EVGN) reported Q3 EPS of ($0.31), $0.12 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $310 thousand versus the consensus estimate of $575 thousand.
For earnings history and earnings-related data on Evogene (EVGN) click here.
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
